The Impact of Tiered Co-Pays A Survey of Patients and Pharmacists

Size: px
Start display at page:

Download "The Impact of Tiered Co-Pays A Survey of Patients and Pharmacists"

Transcription

1 The Impact of Tiered Co-Pays A Survey of Patients and Pharmacists Research Report Conducted by Harris Interactive September, 2003 This study was completed on behalf of and with support from the National Association of Chain Drug Stores Foundation, the National Pharmaceutical Council, and Pfizer Inc , All rights reserved.

2 Contents Background and Objectives Methodology Executive Summary Detailed Findings Patients and Their Health Care Coverage All Patients with Drug Coverage Patients with Employer-Sponsored Health Care Benefits Patient Health Issues: Patients with Employer-Sponsored Health Care Benefits Compliant and Non-Compliant Money Saving Strategies: Patients with Employer-Sponsored Health Care Benefits Page 2

3 Contents (Cont.) Drug Selection Based on Patient Out-of-Pocket Costs: Patients with Employer-Sponsored Health Care Benefits Overview: Pharmacists Managed Care and the Pharmacist s Practice: Pharmacists Non-Compliance & Drug Selection Based on Patient Out-of- Pocket Costs: Pharmacists Page 3

4 Background and Objectives Employers increasingly have adopted strategies to reduce prescription drug expenditures, including cost-sharing arrangements that require employees to pay a greater share of the costs. A highly prevalent strategy is the multi-tier co-pay (MTC) benefit design, with three or more tiers, in which an employee s out-of-pocket cost, or co-pay, for a prescription drug depends on that medicine s tier level. In 2002, approximately 57% of people with employer-sponsored health benefits were enrolled in MTC plans growing from 29% of employees with this benefit design in The growing use of tiered benefit plans and increasing co-pay levels has prompted concern that higher co-pays may lead patients, particularly those with chronic illnesses, to reduce prescription drug compliance and, consequently, experience negative health outcomes that result in increased utilization of other health care services. 1 Source: Kaiser Family Foundation and Health Research and Educational Trust 2002 Employer Health Benefits Survey Page 4

5 Background and Objectives (cont.) In August 2002, The National Association of Chain Drug Stores Foundation, The National Pharmaceutical Council, and Pfizer, Inc. commissioned Harris Interactive to assess and document the impact of tiered prescription drug formularies on the behavior and health outcomes of chronically ill patients. Specifically, this research examines the relationship between multi-tier co-pay benefit plans and: Prescription drug compliance and persistency; Patient health outcomes; and Pharmacy practice. Page 5

6 Methodology: Patient Survey g Harris Interactive conducted 20-minute telephone interviews with 2,711 U.S. adults age 18+ with at least one chronic or recurring health condition and health coverage that includes a drug benefit ( representing 52% of all U.S. adults*). 1,499 interviews were conducted with respondents sampled via random digit dialing (RDD). An additional 1,212 interviews were conducted with respondents, recruited online via the Harris Interactive Chronic Illness panel, with any of four key chronic conditions: asthma, depression, type 2 diabetes, or high cholesterol. These additional interviews ensured sufficient numbers to permit group-level analyses for each of these conditions. Total interviews for each condition: Asthma 435 Depression 404 Type 2 diabetes 589 High Cholesterol 470 The full sample includes patients covered by a range of health care plans, including private insurance, employer-sponsored coverage, Medicare, Medicaid, and coverage through the Veteran s Administration (VA). The prescription drug benefits associated with each of these plans vary greatly. Therefore, to ensure a homogeneous sample, the bulk of the analysis focuses on the most predominant group patients with employer-sponsored coverage. Except where indicated, patients with Medicare, Medicaid, and VA coverage are excluded from the analysis. * Source: Strategic Health Perspectives. Harris Interactive, Page 6

7 Methodology: Patient Survey g Interviews were conducted between December 3, 2002 and January 5, The patient data were weighted, where needed, to be projectable to all adults age 18+ diagnosed with a chronic condition and with prescription drug coverage. To ensure that the results were not biased by the over-representation of people with the four conditions described above, the data were also weighted so that these conditions are represented in correct proportion to their actual incidence among the general population. Page 7

8 Methodology: Pharmacist Survey g 1001 licensed retail pharmacists completed 20-minute self-administered Internet interviews. Pharmacists were sampled from a comprehensive national listing and invited to Harris Interactive s website by US mail. g Interviews were conducted from December 2 through December 13, g The data were weighted to ensure that pharmacists are represented in correct proportion with respect to retail practice setting (chain vs. independent pharmacy) and geographic region. Page 8

9 Methodology: Significance Testing Significance is tested at the 95% confidence level Throughout the report, significance testing is reported using superscripts. Numbers with superscripts are significantly higher/lower than the number in the row or column titled with that superscript. Page 9

10 Executive Summary , All rights reserved.

11 Executive Summary Chronically ill individuals with employer-sponsored coverage are likely to be enrolled in drug benefit plans that require them to pay a co-pay. Seven in ten insured adults who suffer from chronic conditions are covered through employer-sponsored plans. Three in four of those with employer-sponsored coverage have drug benefits involving a co-pay. At least half of individuals with employer-sponsored co-pay benefit plans have tiered co-pays, which require patients to pay more out-of-pocket for some medications than others. 28% of individuals with employer-sponsored co-pay benefit plans are enrolled in plans with 2 tiers; 23% are enrolled in plans with 3 or more tiers. Demographically, chronically ill people in employer-sponsored drug benefit plans with 3 or more tiers (multi-tier co-pays or MTC ) are more likely than adults in general to be female, college-educated, white, and have lower household incomes. Page 11

12 Executive Summary Chronically ill people in multi-tier co-pay drug benefit plans are more likely to report having difficulty paying out-of-pocket costs for medicines. People with MTC plans are much more likely than those in non-tiered, and two-tier plans to report having difficulty paying for their prescription medications. This is not surprising given that they pay about 60% more per month than people in non-tiered plans for their prescription drugs. People with multi-tier co-pay plans are less healthy than their nontiered, and in some cases two-tiered, counterparts. Compared to people with non-tiered employer-sponsored drug plans, those in MTC plans take more medicines. They are also more likely to have visited a hospital emergency room in the past year and make visits to the doctor beyond regular check-ups. They are also more likely to report missing days from work, contacting their health plans, and contacting their health benefits manager at work. Page 12

13 Executive Summary Patients use a variety of strategies to reduce their out-of-pocket costs for prescription drugs. The likelihood of using these strategies is greater among patients with tiered co-pay benefit plans. Eight in ten with MTC plans report requesting a generic, requesting samples, or splitting pills in half with their doctor s permission within the past year, compared to about five in ten individuals with non-tiered copay plans. Patients with tiered co-pay plans more frequently engage in noncompliant behaviors to reduce out-of-pocket costs, including delaying or deciding not to get a prescription filled, or taking smaller doses than prescribed, including splitting pills without the doctor s permission. Half of those with MTC plans report using these non-compliant strategies. They are twice as likely as those in non-tiered plans to use non-compliant strategies (54% vs. 25%). Page 13

14 Executive Summary Asthma and Depression patients in multi-tier co-pay benefit plans are especially likely to use non-compliant strategies in order to save money. Nine in ten asthma sufferers who have MTC employersponsored drug benefit plans report using money saving strategies. Three in four MTC asthma sufferers report using non-compliant strategies within the past year, compared with half that number among asthma sufferers in non-tiered plans (75% vs. 34%). Similarly, over nine in ten depression sufferers in MTC employersponsored plans use money-saving strategies. Three in four (76%) depression sufferers in MTC plans report having been non-compliant within the past year in order to save money, compared with four in ten (42%) depression sufferers in non-tiered plans. Page 14

15 Executive Summary Other key groups who are especially vulnerable to the effects of tiering include the less healthy and the less wealthy. Patients with 3+ tier employer-based drug benefit plans who are in poor health are twice as likely as their non-tiered counterparts to report having been non-compliant within the past year (53% and 66% among those in two- and three-tier plans). In contrast, only about a quarter of those with non-tiered employer plans reported non-compliance, regardless of their health status. Those with annual household incomes under $50,000 are similarly susceptible to the effects of tiering, with 50% and 69% of those with two- and three-tier plans reporting non-compliance, compared to only 29% among those with non-tiered plans. Page 15

16 Executive Summary Non-compliance is not without risk. More than a third report having experienced health problems as a result of engaging in noncompliant behaviors to save on their prescription out-of-pocket drug costs. Again, people with tiered drug plans are disproportionately affected. On average, over a third (37%) of those who engaged in a noncompliant behavior, experienced health problems as a result of doing so. This translates to roughly 14% of all chronically ill adults with drug coverage, or 15.6 million people.* Fully half (51%) of those in three tier plans who engaged in a noncompliant behavior report resultant negative health outcomes, compared with only 26% on average, among those with non-tiered plans. * Based on July 2002 U.S. Census Bureau population estimate of U.S. adults: 215,474,215. Page 16

17 Executive Summary It is relatively common for patients to receive a drug with a lower co-pay specifically for the purpose of reducing patients out of pocket costs One-third (33%) of chronically ill patients with employer-sponsored drug coverage report either switching from a drug they were already taking or receiving a drug with a lower co-pay at the outset (at their own request or by choice of the doctor) for the purpose of saving money. Individuals with MTC drug plans, and those who suffer from depression are most likely to report experiencing this cost-based prescribing. Over four in ten people with depression (43%) report having experienced some form of cost-based prescribing. Over half (54%) of those in MTC plans report having having these experiences, compared with only 17% of those in non-tiered plans and 33% of those in 2-tier plans. Page 17

18 Executive Summary Individuals who have switched medications or received medicines with lower co-pays to save money are more likely than average to report having had problems with their prescription medications, as are individuals with multi-tier drug plans. Those who have received or switched to a drug with a lower co-pay within the past year are about twice as likely as those who have not, to report having taken a drug that was ineffective (25% vs. 12%). They are also twice as likely to report taking a drug that caused side effects (27% vs. 14%). Almost three in ten individuals (27%) with MTC plans report having taken a medication in the past year that was ineffective, and about the same number (29%) experienced side effects from a medication. Page 18

19 Executive Summary Pharmacists confirm the experiences reported by patients, reporting that patient non-compliance is a common occurrence. Two-thirds (65%) report that patients delay getting prescriptions filled very or somewhat often in order to reduce their out-of-pocket costs for prescription drugs. A majority also report that patients somewhat or very often decide not to get prescriptions filled (57%) and take their medications less frequently than prescribed (56%) in order to save money. Page 19

20 Executive Summary By an overwhelming majority, pharmacists suspect that patients take less than optimal drugs due to insurance restrictions. They also believe that the substituted drugs may be ineffective or cause side effects. Nine in ten (90%) pharmacists suspect that their patients with drug coverage end up taking less-than-optimal medications because of insurance restrictions. Half (51%) believe that it is somewhat or very common that the substituted drug is not effective. Four in ten (39%) believe it is somewhat or very common that the substituted drug causes side effects. About two-thirds (64%) believe that it is somewhat or very common that patients end up making additional visits to a doctor as a result of drug substitution. Page 20

21 Executive Summary Pharmacists have a lot of experience dealing with drug plans and they know them well. The surveyed pharmacists have been in practice an average of 17 years and these pharmacists fill more than 750 prescriptions per average week. On average, 80% of these are covered by some type of drug plan half (52%) by plans that involve a co-pay. Nearly nine in ten (87%) pharmacists say that they are somewhat or very knowledgeable about options under multi-tier drug plans. In contrast, 92% believe that patients are either not at all or not very knowledgeable about options under these plans. Prescriptions most commonly filled include antidepressants, analgesics, diabetes therapy, vascular agents, and oral anti-infectives. Since becoming widespread, multi-tiered drug plans have caused more pharmacists to spend time dealing with patients about their drug benefits than about their treatments. Eight in ten pharmacists say that, since multi-tier drug plans have become widespread, they spend somewhat or much more time dealing with health plans (82%) and educating patients about their drug benefits (83%). Only a little more than a quarter (27%) spend more time communicating with and educating their patients about their medications. Page 21

22 Executive Summary Ideally, pharmacists would spend more of their time communicating with patients and less time dealing with health plans. Pharmacists spend most of their time filling prescriptions ranking this activity higher than any other in terms of actual time spent. However pharmacists would prefer to spend most of their time communicating with and educating patients on their treatments ranking this activity #1 in terms of time ideally spent. Pharmacists ranked communicating with health plans last among their list of ideal activities. Working with these plans has become more difficult in the last five years, and has made pharmacists jobs more difficult. Among those in practice at least five years, 85% say that working with the typical health plan today is somewhat or much more difficult than working with the typical health plan five years ago. 87% also say that their jobs are more difficult today overall than they were five years ago; among this group, nine in ten say that the move toward drug formularies (92%) and multi-tier drug plans (92%) are the cause of the difficulty. Page 22

23 Detailed Findings , All rights reserved.

24 Patients and Their Health Care Coverage All Patients With Drug Coverage , All rights reserved.

25 Types of Patient Health Care Coverage All Patients With Drug Coverage Most patients with health insurance and prescription drug coverage are covered through an employment-based health care plan. Health insurance or an HMO through your or someone else's work or union 71% Health insurance or an HMO bought directly by you or another member of your family 35% Medicare or a Medicare HMO 28% Medicaid, Medicaid HMO, or medical assistance 15% Health coverage through the Veteran's Administration 7% Health insurance from some other source 19% Note: percentages exceed 100% because some patients have health coverage through more than one source. Q320: People have different kinds of health plans or health insurance, including those provided by the government. Are you covered by (READ EACH ITEM), or not? Base: All Respondents (n=2711) Page 25

26 Demographic Profile by Health Care Coverage All Patients With Drug Coverage Gender Male Female US Adults Age 18+ % Employer-Sponsored Coverage* (n=1501) % Medicare (n=456) % Medicaid (n=349) % VA Coverage (n=158) % Age (mean years) College degree Married Income Less than $50,000 $50,000 or more Race White Minority * Throughout this report, the employer-sponsored coverage group excludes those who also have coverage through Medicare, Medicaid or the Veteran s Administration. Page 26

27 Type of Drug Benefit by Health Care Coverage All Patients With Drug Coverage Employer-Sponsored Coverage (n=1501) (a) % Medicare (n=456) (b) % Medicaid (n=349) (c) % VA Coverage (n=158) (d) % Total Co-Pay c c Co-Insurance d Combination Not sure bd 17 b Co-pay Plans Non-Tiered b 48 b 2 Tiers tiers cd 5 7 Not sure c 5 12 c Q600, 605, 610, 615, 620, 625 (see questionnaire Appendix B) Base: All Respondents Page 27

28 Patients and Their Health Care Coverage All Patients With Drug Coverage Patients With Employer-Sponsored Health Care Benefits , All rights reserved.

29 Combination 8% Drug Coverage Patients With Employer-Sponsored Health Care * Not Sure 3% Co- Insurance 13% All Plans 3+ Tiers 25% Not Sure 11% Co-Pay Plans Non- Tiered 35% Co-Pay 75% 2 Tiers 28% Q600, 605, 610, 615, 620, 625 Base: All Respondents (n=1501) * Note: Combination plans are those in which patients pay a co-pay for some drugs and a percentage (co-insurance) for other drugs. Combination plans are presented alongside co-insurance plans in this analysis for purposes of convenience. Page 29

30 Demographic Profile by Co-pay Coverage Patients With Employer-Sponsored Health Care Gender Male Female All US Adults Age 18+ % Total w/ Employer Coverage (n=1501) a % b Non-tiered (n=365) b % 53 ac 47 2 Tiers (n=335) c % b 3+ Tiers (n=274) d % 37 a 63 abc Age (mean years) College degree b b 38 ab Married Income Less than $50,000 $50,000 or more Race White Minority b 19 c acd b abc b 15 Page 30

31 Patient Chronic Conditions by Co-Pay Coverage Patients With Employer-Sponsored Health Care Patients in tiered co-pay plans are more likely than adults in general and those in non-tiered plans to suffer from depression. Percent With Diagnosed Medical Condition Total (n=1501) (a) Non-tiered (n=365) (b) 2 Tiers (n=335) (c) 3+ Tiers (n=274) (d) Diabetes High Cholesterol Allergies Asthma Hypertension Depression b 24 Arthritis Q400. (Do you have any recurring or chronic health condition diagnosed by a health professional that has lasted or is expected to last for at least a year?) What condition is that? Please name all recurring or chronic medical conditions that you have. Base: All Respondents Page 31

32 Overall Health by Co-pay Coverage Patients With Employer-Sponsored Health Care Patients in MTC co-pay plans are more likely than others to report being in fair or poor health Excellent/Very Good Health Fair/Poor Health 47% 41% 36% 39% b 33% a,b,c 30% 38% 27% 11% 9% 9% 27% 12% 22% 5% 17% 17% 4% 13% 23% 3% 20% 7% 26% Total (a) Non-tiered (b) 2 Tiers (c) 3+ Tiers (d) Total (a) Non-tiered (b) 2 Tiers (c) 3+ Tiers (d) Excellent Very Good Fair Poor Q330. Would you say your health, in general, is excellent, very good, good, fair or poor? Base: All Respondents (total n=1501; non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 32

33 Patient Health Issues Patients With Employer-Sponsored Health Care Benefits , All rights reserved.

34 Patient Health Issues Past 12 Months Patients With Employer-Sponsored Health Care In the past 12 months, two-thirds of patients have contacted a doctor for a reason other than a regular check-up, and almost half have contacted their health plan or insurance company. Percent who Experienced Health Issue Mean # of times experienced Make any visits to a doctor in addition to regular check-ups 66% Make any visits to a doctor in addition to regular check-ups 6.1 Contact your health plan or insurance company 48% Contact your health plan or insurance company 3.7 Miss any days from w ork 42% Miss any days from w ork 12.4 Visit a hospital ER 22% Visit a hospital ER 1.6 Admitted to a hospital 17% Admitted to a hospital 1.6 Visit an urgent care facility 18% Visit an urgent care facility 2.2 Contact health benefits manager at work 18% Contact health benefits manager at work 2.3 Q500. In the past 12 months, for any reason did/were you [INSERT ITEM], or not? Base: All Respondents (n=1501) Q510. And how many times did that happen in the past 12 months? Base: Have Done Action in Past 12 Months (n=1073) Page 34

35 Past Year Health Issues Patients With Employer-Sponsored Health Care Patients with MTC plans are more likely than those with non-tiered plans to have visited an emergency room or been admitted to a hospital in the past year. % Who Experienced Each Health Issue 22% 23% 27% a 19% 19% 16% 16% 18% 19% Visit an urgent care facility Admitted to a hospital Visit a hospital ER Non-Tiered (a) 2 Tiers (b) 3+ Tiers (c) Q500. In the past 12 months, for any reason did/were you [INSERT ITEM], or not? Base: All Respondents (non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 35

36 Past Year Health Issues Patients With Employer-Sponsored Health Care (cont.) Patients with MTC plans are more likely to have contacted their health benefits manager or insurance company, missed days from work, or made a special visit to the doctor. % Who Experienced Each Health Issue 61% a,b 67% a 73% a 40% 38% 49% b 43% 45% 54% 16% 19% 25% a Contact health benefits manager at work Miss any days from work Contact your health plan or insurance company Non-Tiered (a) 2 Tiers (b) 3+ Tiers (c) Make any visits to a doctor in addition to regular check-ups Q500. In the past 12 months, for any reason did/were you [INSERT ITEM], or not? Base: All Respondents (non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 36

37 Past Year Prescription Medication Patients With Employer-Sponsored Health Care Nearly all patients have taken prescription medication in the past year. Patients with MTC plans are more likely than those with non-tiered plans to have taken a prescription medication in the past year. Took Rx Medication 84% 82% 90% b 92% b Total (a) Non-Tiered (b) 2 Tiers (c) 3+ Tiers (d) Q405. In the past 12 months, have you taken any prescription medications to treat a chronic or recurring health or medical condition? Base: All Respondents (total n=1501; non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 37

38 Number of Rx Medications Patients With Employer-Sponsored Health Care Patients with MTC plans take more prescription medications than those in non-tiered plans. Mean # of Medications 3.1 b,c b 2.1 b b Past 12 Months Total Current Medications Total (a) Non-Tiered (b) 2 Tiers (c) 3+ Tiers (d) Q415: How many different prescription medications, in total, have you taken in the past 12 months for (CONDITION)? Q420: And how many different prescription medications, in total, do you CURRENTLY take for (CONDITION)? Base: All Respondents (total n=1501; non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 38

39 Difficulty Paying Out-of-Pocket Costs Patients With Employer-Sponsored Health Care People with MTC plans are much more likely than others to report having difficulty paying for their prescription medications perhaps not surprising, given that they pay about $50 per month more than people in two-tier plans and $40 per month more than people in non-tiered plans for their prescription drugs. Average monthly out-ofpocket cost $70.00 $60.30 $47.40 $97.60 c 46% b,c 30% b,c,d % Responding Extremely/Somewhat Difficult To Pay Out-of-Pocket Costs 19% 24% Total (a) Non-Tiered (b) 2 Tiers (c ) 3+ Tiers (d) Q680 Not counting the amount covered by your health plan, about how much do you spend per month out-of-pocket for your prescription medicines? Base: All Respondents (total n=1501; non-tiered n=365; 2 tiers n=335; 3+ tiers n=274). Q690 How difficult is it for you to pay the out-of-pocket costs for your prescription medications extremely difficult, somewhat difficult, not too difficult, or not at all difficult? Base: Out-of-Pocket Costs are Greater Than Zero (total n=1336; non-tiered n=312; 2 tiers n=313; 3+ tiers n=263). Page 39

40 Compliant and Non-Compliant Money Saving Strategies Patients With Employer-Sponsored Health Care Benefits , All rights reserved.

41 Defining Compliance In this study, we refer to two distinct sets of behaviors patients use to save on their out-of-pocket costs for prescription medicines. Compliant strategies include: Requesting a generic drug, Asking physician for samples, and Splitting pills in half with doctor s permission. Non-compliant strategies include: Deciding not to get a prescription filled, Delaying getting a prescription filled, Taking smaller doses of a medication than prescribed or splitting pills in half without a doctor s permission, and Taking a medication less frequently than prescribed. Page 41

42 Strategies to Reduce Out-Of-Pocket Costs for Prescription Medicines Patients With Employer-Sponsored Health Care Two-thirds of all patients engaged in some strategy to save money. Used any strategy to save money 67% * Used any compliant strategy 60% Requested a generic drug instead of a name brand 48% Asked physician for samples 37% Split pills in half with doctor's permision 11% * Used any non-compliant strategy 37% Delayed getting a Rx filled 27% Decided not to get a Rx filled 23% Taken medication less frequently than prescribed 19% Taken smaller doses of a medication or split pills in half without doctor's permission 10% Q700. In the past 12 months, have you done any of the following in order to reduce your out-of-pocket costs for prescription medications? Please answer yes only if the main reason you did this was to save money. Have you? Base: All Respondents (total n=1501) Page 42

43 Strategies to Reduce Out-of-Pocket Costs by Co-pay Coverage Patients With Employer-Sponsored Health Care Patients in MTC plans are more likely than others to use these strategies. Used any strategy to save money 52% 67% a 86% a,b Used any compliant strategy 45% 63% a 78% a,b Requested a generic drug instead of a name brand 29% 48% a 68% a,b Asked physician for samples 26% 37% a 49% a,b Split pills in half with doctor's permision 8% 10% 17% a,b Non-Tiered (a) 2 tiers (b) 3+ Tiers (c) Q700. In the past 12 months, have you done any of the following in order to reduce your out-of-pocket costs for prescription medications? Please answer yes only if the main reason you did this was to save money. Have you? Base: All Respondents (non-tiered n=365; 2 tiers n=335; 3+ tiers n=274 ) Page 43

44 Strategies to Reduce Out-of-Pocket Costs by Co-pay Coverage Patients With Employer-Sponsored Health Care Patients in MTC plans are more likely than others to use non-compliant strategies. Used any non-compliant strategy 25% 33% 54% a,b Delayed getting a Rx filled 18% 22% 43% a,b Decided not to get a Rx filled 11% 18% a 38% a,b Taken medication less frequently than prescribed 12% 16% 31% a,b Taken smaller doses of a medication or split pills in half without doctor's permission 5% 8% 14% a Non-Tiered (a) 2 tiers (b) 3+ Tiers (c) Q700. In the past 12 months, have you done any of the following in order to reduce your out-of-pocket costs for prescription medications? Please answer yes only if the main reason you did this was to save money. Have you? Base: All Respondents (non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 44

45 Health Problems Resulting From Non-Compliance by Co-pay Coverage Patients With Employer-Sponsored Health Care Patients in MTC plans are twice as likely to experience health problems as a result of non-compliance as those in non-tiered plans. Experienced health problems as a result of non-complaint behavior 39% 51% 26% Non-Tiered (a) 2 tiers (b) 3+ Tiers (c) Q710. In the past 12 months, do you believe you experienced any health problems as a result of [INSERT ITEM] in order to save money? Base: Have Done Non-compliant Behavior (non-tiered n=76; 2 tiers n=106; 3+ tiers; n=143) Page 45

46 Patient Strategies to Reduce Out-of-Pocket Costs: by Condition and Co-Pay Coverage Patients With Employer-Sponsored Health Care Asthma Depression Total n=267 (A) Non-tiered n=54 (B) 2 Tiers n=70 (C) 3+ Tiers n=56 (D) Total n=231 (A) Non-tiered n=41 (B) 2 Tiers n=65 (C) 3+ Tiers n=57 (D) Used any strategy to save money b 91 bc b 94 bc Used any compliant strategy b 88 bc b 85 b -Requested a generic drug b 74 bc b 69 b -Asked physician for samples b 62 bc b 67 b -Split pills in half with doctor s permission bc b Used any non-compliant strategy bc bc -Delayed getting a Rx filled bc bc -Decided not to get a Rx filled bc bc -Taken Rx less frequently than prescribed bc bc -Taken smaller doses of medication or split pills without doctor s permission c Page 46

47 Patient Strategies to Reduce Out-of-Pocket Costs: by Condition and Co-Pay Coverage (cont.) Patients With Employer-Sponsored Health Care Type 2 Diabetes High Cholesterol Total n=325 (A) Non-tiered n=60 (B) 2 Tiers n=91 (C) 3+ Tiers n=76 (D) Total n=259 (A) Non-tiered n=66 (B) 2 Tiers n=66 (C) 3+ Tiers n=54 (D) Used any strategy to save money bc bc Used any compliant strategy b 81 bc b -Requested a generic drug b 71 bc b -Asked physician for samples b 48 b b -Split pills in half with doctor s permission b Used any non-compliant strategy bc -Delayed getting a Rx filled b 35 bc bc -Decided not to get a Rx filled c bc -Taken Rx less frequently than prescribed c -Taken smaller doses of medication or split pills without doctor s permission b 19 b Page 47

48 Patient Strategies to Reduce Out-of-Pocket Costs: by Income and Co-Pay Coverage Patients With Employer-Sponsored Health Care Total n=584 (A) Less Than $50,000 per Year Non-tiered n=142 (B) 2 Tiers n=120 (C) 3+ Tiers n=119 (D) Total n=787 (A) $50,000 per Year or More Non-tiered n=177 (B) 2 Tiers n=187 (C) 3+ Tiers n=139 (D) Used any strategy to save money b 92 bc b 79 bc Used any compliant strategy b 85 bc b 71 bc -Requested a generic drug b 72 bc b 65 bc -Asked physician for samples b 57 bc b 43 b -Split pills in half with doctor s permission c 6 26 bc b 8 Used any non-compliant strategy b 69 bc bc -Delayed getting a Rx filled b 58 bc bc -Decided not to get a Rx filled b 48 bc bc -Taken Rx less frequently than prescribed bc bc -Taken smaller doses of medication or split pills without doctor s permission b 20 b b Page 48

49 Patient Strategies to Reduce Out-of-Pocket Costs: by Health Status and Co-Pay Coverage Patients With Employer-Sponsored Health Care Excellent/Very Good Health Fair/Poor Health Total Nontiered Non- Tiered 2 Tiers 3+ Tiers Total 2 Tiers 3+ Tiers n=594 (A) n=173 (B) n=116 (C) n=87 (D) n=332 (A) n=58 (B) n=81 (C) n=82 (D) Used any strategy to save money b 82 bc b 90 bc Used any compliant strategy b 73 b b 85 b -Requested a generic drug b 64 bc b 81 bc -Asked physician for samples b b -Split pills in half with doctor s permission bc Used any non-compliant strategy bc b 66 b -Delayed getting a Rx filled bc b 59 bc -Decided not to get a Rx filled bc b 50 bc -Taken Rx less frequently than prescribed b 47 b -Taken smaller doses of medication or split pills without doctor s permission Page 49

50 Patient Strategies to Reduce Out-of-Pocket Costs: by Gender and Co-Pay Coverage Patients With Employer-Sponsored Health Care Male Female Total Nontiered Nontiered 2 Tiers 3+ Tiers Total 2 Tiers 3+ Tiers n=530 (A) n=157 (B) n=124 (C) n=77 (D) n=971 (A) n=208 (B) n=211 (C) n=197 (D) Used any strategy to save money b 80 bc bc Used any compliant strategy b 75 bc bc -Requested a generic drug b 69 bc b 68 bc -Asked physician for samples b b 56 bc -Split pills in half with doctor s permission bc Used any non-compliant strategy b 34 b bc -Delayed getting a Rx filled bc -Decided not to get a Rx filled b 26 b bc -Taken Rx less frequently than prescribed b 22 b bc -Taken smaller doses of medication or split pills without doctor s permission b b Page 50

51 Patient Strategies to Reduce Out-of-Pocket Costs: by Age and Co-Pay Coverage Patients With Employer-Sponsored Health Care Under Age 50 Age 50+ Total Nontiered Nontiered 2 Tiers 3+ Tiers Total 2 Tiers 3+ Tiers n=806 (A) n=184 (B) n=161 (C) n=162 (D) n=657 (A) n=172 (B) n=168 (C) n=105 (D) Used any strategy to save money b 89 bc bc Used any compliant strategy b 80 bc b 75 bc -Requested a generic drug b 69 bc b 70 bc -Asked physician for samples b 52 b bc -Split pills in half with doctor s permission bc bc Used any non-compliant strategy bc b -Delayed getting a Rx filled bc b 26 b -Decided not to get a Rx filled b 44 bc b 21 b -Taken Rx less frequently than prescribed bc b -Taken smaller doses of medication or split pills without doctor s permission b b 7 Page 51

52 Patient Strategies to Reduce Out-of-Pocket Costs: by Education and Co-Pay Coverage Patients With Employer-Sponsored Health Care College Graduate Non-College Graduate Total Nontiered Nontiered 2 Tiers 3+ Tiers Total 2 Tiers 3+ Tiers n=732 (A) n=151 (B) n=166 (C) n=145 (D) n=747 (A) n=208 (B) n=166 (C) n=125 (D) Used any strategy to save money b 76 bc b 93 bc Used any compliant strategy b 67 b b 86 bc -Requested a generic drug b 59 bc b 75 bc -Asked physician for samples bc b 55 bc -Split pills in half with doctor s permission bc Used any non-compliant strategy bc b 62 bc -Delayed getting a Rx filled bc b 54 bc -Decided not to get a Rx filled b 29 bc b 44 bc -Taken Rx less frequently than prescribed bc b 37 bc -Taken smaller doses of medication or split pills without doctor s permission b b Page 52

53 Drug Selection Based on Patient Out-of-Pocket (OOP) Costs Patients With Employer-Sponsored Health Care Benefits , All rights reserved.

54 OOP Cost-Based Drug Selection: Three Scenarios Patients With Employer-Sponsored Health Care One in three experienced some form of cost-based drug selection within the past year. Experienced any cost-based drug selection 33% - Patient asked doctor or pharmacist to give them less costly drug 23% - Doctor chose one drug over another to save patient money 19% - Patient switched from drug already taking to less expensive drug to save money 13% Q800 In the past 12 months, has your doctor chosen a particular drug for you instead of another drug he or she might prescribe in order to save you money? Q805 In the past 12 months, have you asked your doctor or pharmacist to give you a drug that would cost you less money than another drug you might be prescribed? Q810 In the past 12 months, have you had to switch from a drug you had already been taking to a less expensive drug in order to save money? Base: All Respondents (total n=1501) Page 54

55 OOP Cost-Based Drug Selection by Health Condition Patients With Employer-Sponsored Health Care People with depression are especially likely to experience cost-based drug selection. Asthma (n=267) % a Depression (n=231) % b Type 2 Diabetes (n=325) % c High Cholesterol (n=259) % d Experienced any cost-based drug selection Patient asked doctor or pharmacist to give them less costly drug Doctor chose one drug over another to save patient money Patient switched from drug already taking to less expensive drug to save money 8 20 a a Q800 In the past 12 months, has your doctor chosen a particular drug for you instead of another drug he or she might prescribe in order to save you money? Q805 In the past 12 months, have you asked your doctor or pharmacist to give you a drug that would cost you less money than another drug you might be prescribed? Q810 In the past 12 months, have you had to switch from a drug you had already been taking to a less expensive drug in order to save money? Base: All Respondents Page 55

56 OOP Cost-Based Drug Selection by Co-Pay Coverage Patients With Employer-Sponsored Health Care People with MTC plans are twice as likely as those in non-tiered plans to experience cost-based drug selection. Experienced any cost-based drug selection 17% 33% 54% a,b -Patient asked doctor or pharmacist to give them less costly drug 12% 24% 41% a,b -Doctor chose one drug over another to save patient money 9% 17% a 34% a,b -Patient switched from drug already taking to less expensive drug to save money 7% 11% 21% a,b Non-Tiered (a) 2 tiers (b) 3+ Tiers (c) Q800 In the past 12 months, has your doctor chosen a particular drug for you instead of another drug he or she might prescribe in order to save you money? Q805 In the past 12 months, have you asked your doctor or pharmacist to give you a drug that would cost you less money than another drug you might be prescribed? Q810 In the past 12 months, have you had to switch from a drug you had already been taking to a less expensive drug in order to save money? Base: All Respondents (non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 56

57 Problems With Medication in Past Year: by OOP Cost-Based Drug Selection Patients With Employer-Sponsored Health Care Patients who experienced cost-based drug selection are twice as likely as those who haven t to report experiencing problems with their medications in the past year. b 25% 27% b 14% 12% Not being effective in treating the condition for which it was prescribed Experienced Cost-Based Drug Selection (a) Causing negative side-effects No Cost-Based Drug Selection (b) Q520. Thinking about any medication you have taken for a chronic condition in the past 12 months, was there ever a problem with that medication? Base: Taken R X Medication for Chronic Illness (total n=2365; experienced drug substitution n=791; no substitution n=1503) Page 57

58 Problems With Medication in Past Year: by Co-pay Coverage Patients With Employer-Sponsored Health Care Patients in MTC plans are twice as likely as those in non-tiered plans to report experiencing problems with their medications in the past year. Not being effective in treating the condition for which it was prescribed 12% 22% a 27% a Causing negative side-effects 15% 25% a 29% a Non-Tiered (a) 2 Tiers (b) 3+ Tiers (c) Q520. Thinking about any medication you have taken for a chronic condition in the past 12 months, was there ever a problem with that medication? Base: Taken R X Medication for Chronic Illness (non-tiered n=309; 2 tiers n=301; 3+ tiers n=256) Page 58

59 Topics Discussed With Pharmacist Patients With Employer-Sponsored Health Care Patients in MTC plans are much more likely than others to discuss less expensive medication alternatives and details of their drug plans. b a 55% 53% 53% 44% 45% 39% 40% 36% 45% 45% 45% 41% a,b 21% 11% 11% 9% a,b 28% a 25% 18% 18% 15% Alternative medications that may cost less Details of drug plan Other treatments for condition Dosage Other medicines that might interact How/when to take the Rx Possible side effects Non-tiered (a) 2 Tiers (b) 3+ Tiers (c) Q900. Thinking of the times when you go to a pharmacy to get a new prescription filled or pick up the prescription, do you typically discuss with a pharmacist? Base: All Respondents (non-tiered n=365; 2 tiers n=335; 3+ tiers n=274) Page 59

60 Overview Pharmacists , All rights reserved.

61 Pharmacist Practice Demographics Total % Pharmacy Type Chain 66 Independent 34 Total % Chain Independent Region East 20 (%) 19 (%) 22 South Midwest West Years in Practice < or more Average Years in Practice Average Prescriptions Filled Per Week Average Hours Worked Per Week Q330. For how many years in total have you practiced as a pharmacist in retail settings? Q335. Approximately how many prescriptions do you personally fill per average week? Q340. In an average week, approximately how many hours do you work as a retail pharmacist? Base: All Qualified Respondents (n=1001) Page 61

62 Prescriptions Filled by Therapeutic Class Pharmacists % Who Listed Drug Class Among Top 5 Most Frequently Filled Prescriptions Psychotherapeutics Antianxiety 30 Psychotherapeutics Antidepressants 64 Psychotherapeutics Antipsychotics 5 Psychotherapeutics Other 1 Vascular agents - ARBs, including ACEs 44 Vascular agents - Alpha blockers, Beta blockers, Alpha-beta blockers 31 Vascular agents CCBs 4 Vascular agents - Other 1 Oral systemic anti-infectives 42 Analgesics 61 Hormones 25 Respiratory therapy 12 Top 5 most frequently filled prescriptions are indicated in red Q345. For which 5 classes of drugs do you most frequently fill prescriptions? Please choose up to 5 drug classes from the list below. Base: All Qualified Respondents (n=1001) Page 62

63 Prescriptions Filled by Therapeutic Class (cont.) Pharmacists % Who Listed Drug Class Among Top 5 Most Frequently Filled Prescriptions Gastrointestinal 25 Antiarthritics 10 Antihyperlipidemics 30 Diabetes therapy 48 Diuretics 7 Neurologic - Anti-seizure medications 8 Neurologic Neuralgia 6 Neurologic - Alzheimer s disease/dementia 1 Neurologic Other 2 Thyroid therapy 18 Antihistamines 17 Cardiac agents - Coronary vasodilators 5 Cardiac agents - Positive inotropic agent 1 Oral anti-fungal agents * Genitourinary 1 Top 5 most frequently filled prescriptions are indicated in red Q345. For which 5 classes of drugs do you most frequently fill prescriptions? Please choose up to 5 drug classes from the list below Base: All Qualified Respondents (n=1001) Page 63

64 Prescriptions Covered by Health Plan/Insurance Pharmacists 80% of all prescriptions pharmacists fill are covered by some kind of health plan. Mean % of Total Total Prescriptions Filled Per Week # Covered by Insurance or Health Plan # Covered by plans with co-pay* # Covered by plans with coinsurance* # Covered by plans with combination of both* Prescriptions (per week) denied coverage due to steptherapy restrictions Q335. Approximately how many prescriptions do you personally fill per average week? Q410. In an average week, approximately how many of the prescriptions you fill are paid, at least in part, by an insurance company or health plan? Q500/501. Approximately how many of the prescriptions you fill in an average week (that are covered by an insurance company or health plan) are covered by each of the following? Q505. About how many times in the past four weeks was coverage for a prescription you tried to fill denied because it was out of sequence in a mandated step-therapy requirement? (re-calculated as number per week) Base: All Qualified Respondents (n=1001) *Base: Fill prescriptions that are covered by Insurance/Health Plan Page 64

65 Knowledge of Multi-Tier Drug Plans Pharmacists Pharmacists are very confident in their own understanding of options available under multi-tier drug plans, but believe patients are far less knowledgeable. 64% 52% 40% 23% 8% 10% 0% 2% Very knowledgeable Somewhat knowledgeable Not very knowledgeable Not at all knowledgeable Pharmacists' Assessment of Patient Knowledge Pharmacists' Assessment of Own Knowledge Q510. In your opinion, how knowledgeable are patients about the options they have under the multi-tier drug plans? Q515. How knowledgeable are you, as a pharmacist, about the options patients have under their multi-tier drug plans? Base: All Qualified Respondents (n=1001) Page 65

66 Knowledge of Multi-Tier Drug Plans Independent vs. Chain Pharmacists Chain and independent pharmacists give similar assessments of their knowledge of options available under multi-tier drug plans. Patients Knowledge Pharmacists Knowledge 49% 53% 42% 39% 66% 62% 25% 21% 9% 7% 11% 10% 0% 0% 2% 3% Very knowledgeable Somewhat knowledgeable Not very knowledgeable Not at all knowledgeable Independent (a) Very knowledgeable Chain (b) Somewhat knowledgeable Not very knowledgeable Not at all knowledgeable Q510. In your opinion, how knowledgeable are patients about the options they have under the multi-tier drug plans? Q515. How knowledgeable are you, as a pharmacist, about the options patients have under their multi-tier drug plans? Base: All Qualified Respondents (Independent: n=320; Chain: n=681) Page 66

67 Time Spent On Professional Activities Actual vs. Ideal Pharmacists Pharmacists would ideally spend more time educating patients and less time communicating with health plans Activity Filling prescriptions including compounding, counting/measuring doses, labeling, controlled substance reporting, checking for interactions, etc. Mean Rank Order Actual 1 Ideal 2 Communicating with/educating patients on treatments, dosages, how to take medications, etc. Communicating with health plans/insurers about patients drug benefits, including required paperwork Performing administrative tasks including order entry, bookkeeping, managing staff, etc. Communicating with/educating patients on their drug benefits, etc. Communicating with physicians about patients drug benefits * 3 4* Q400/401. Please rank each of the following activities in terms of the amount of time you spend performing them in a typical week, where 1 = spend most time performing and 6 = spend least time of amount on. Q405/406. Now rank each of the following activities in terms of how much time you would ideally like to spend on them, where 1 = spend most time performing and 6 = spend least time of amount on. Base: All Qualified Respondents (n=1001) * Indicates a tie Page 67

68 Managed Care and The Pharmacist s Practice Pharmacists , All rights reserved.

69 Effects of Managed Health Care/Formularies: Job Difficulty Pharmacists Almost nine in ten pharmacists say their jobs are more difficult now compared to 5 years ago. They attribute much of the difficulty to drug formularies. Job Difficulty vs. Five Years Ago Causes of Job Difficulty 4% Much/Somewhat Easier 9% About The Same 92% 29% 92% 39% 87% 36% Somewhat A Great Deal 42% Much More Difficult 45% Somewhat More Difficult 63% 53% 51% 36% 30% 6% The move toward drug formularies Multi-tier drug plans Rising out-ofpocket costs for consumers More alert consumers Q820. Compared to 5 years ago, would you say that overall your job has become.? Base: 5 Years in a Retail Setting Q825. To what extent is this due to each of the following? Base: Job Has Become Somewhat/Much More Difficult Page 69

70 Job Difficulty vs. Five Years Ago by Years in Practice Pharmacists Pharmacists say their jobs are more difficult compared to five years ago, regardless of how long they have been practicing. Job Somewhat/Much More Difficult 88% 84% 88% 90% Total (a) Less than 10 Years (b) Years (c) 23 Years or More (d) # Years in Practice Q820. Compared to 5 years ago, would you say that overall your job has become.? Base: 5 Years in a Retail Setting (n=856) Page 70

71 Changes in Professional Activities as a Result of Multi-Tier Drug Plans Pharmacists Pharmacists spend more time now performing some of the activities they least prefer. Percent Who Spend Somewhat/Much More Time on Each Task Than They Did Before These Plans became Widespread Ideal Rank Communicating with/educating patients on their drug benefits, etc. Communicating with health plans/insurers about patients drug benefits, including required paperwork Communicating with physicians about patients drug benefits * Performing administrative tasks including order entry, bookkeeping, managing staff, etc. Filling prescriptions including compounding, counting/measuring doses, labeling, controlled substance reporting, checking for interactions, etc. Communicating with/educating patients on treatments, dosages, how to take medications, etc. * Indicates a tie * 2 1 Q800/801. Have multi-tier drug plans caused you to spend less time, about the same, or more time on each of the following tasks than you did before such plans became widespread? Base: 5 Years in Retail Setting (n=856) Q405/406. Now rank each of the following activities in terms of how much time you would ideally like to spend on them, where 1 = spend most time performing and 6 = spend least time of amount on. Base: All Qualified Respondents (n=1001) Page 71

2015 Survey on Prescription Drugs

2015 Survey on Prescription Drugs 2015 Survey on Prescription Drugs AARP Research January 26, 2016 (For media inquiries, contact Gregory Phillips at 202-434-2544 or gphillips@aarp.org) https://doi.org/10.26419/res.00122.001 Objectives

More information

Pharmaceutical Liability Study Report on Findings

Pharmaceutical Liability Study Report on Findings Pharmaceutical Liability Study Report on Findings Prepared for: U.S. Chamber Institute for Legal Reform July 15, 2003 www.harrisinteractive.com 2003, All rights reserved. Table of Contents Background and

More information

http://results.harrispollonline.com/surveyresults/default.asp?file=page1.html In general, how would you describe your own health? 16% 34% 29% 13% 7% Excellent Very good Good Fair Poor http://results.harrispollonline.com/surveyresults/default.asp?file=page2.html

More information

FINAL TOPLINE. Diabetes Group. Qualities That Matter: Public Perceptions of Quality in Diabetes Care, Joint Replacement and Maternity Care

FINAL TOPLINE. Diabetes Group. Qualities That Matter: Public Perceptions of Quality in Diabetes Care, Joint Replacement and Maternity Care FINAL TOPLINE Group Qualities That Matter: Public Perceptions of Quality in Care, Joint Replacement and Maternity Care National Survey of adults recently diagnosed with type 2 diabetes about their perceptions

More information

Insulin Affordability Survey, 2018

Insulin Affordability Survey, 2018 Insulin Affordability Survey, 2018 May 22, 2018 Insulin Affordability Survey 1 Objectives American Diabetes Association (ADA) engaged a full-service research and accounting firm,, to explore perceptions

More information

EXAMPLE ONLY. RxBIN Issuer (80840) ID NAME Drew Zehnder. Houston Methodist 6565 Fannin Street, GB164 Houston, TX 77030

EXAMPLE ONLY. RxBIN Issuer (80840) ID NAME Drew Zehnder. Houston Methodist 6565 Fannin Street, GB164 Houston, TX 77030 Houston Methodist 6565 Fannin Street, GB164 Houston, TX 77030 00001 RxBIN 004336 RxPCN ADV RxGRP RX3151 Issuer (80840) 9151014609 ID NAME 111111111 Drew Zehnder Present this Prescription Card to fill your

More information

SURVEY ABOUT YOUR PRESCRIPTION CHOICES

SURVEY ABOUT YOUR PRESCRIPTION CHOICES Editor s Note: This online data supplement contains supplemental material that was not included with the published article by William Shrank and colleagues, Patients' Perceptions of Generic Medications,

More information

Your Prescription Card. Your guide for savings.

Your Prescription Card. Your guide for savings. CVS Caremark 620 Epsilon Drive Pittsburgh, PA 15238 4750-_PM 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 Your Prescription Card. Your guide for savings. Dear Plan Member, Welcome to your new benefits. Attached

More information

AreAmericansage45+ UsingPrescriptionDrugs Wisely:A2006Study

AreAmericansage45+ UsingPrescriptionDrugs Wisely:A2006Study AreAmericansage45+ UsingPrescriptionDrugs Wisely:A2006Study February2007 Are Americans age 45+ Using Prescription Drugs Wisely: A 2006 Study Report prepared by Laura Skufca, M.A. AARP Knowledge Management

More information

THE EMERGE SURVEY ON TAKING PART IN BIOBANK RESEARCH: VERSION A

THE EMERGE SURVEY ON TAKING PART IN BIOBANK RESEARCH: VERSION A THE EMERGE SURVEY ON TAKING PART IN BIOBANK RESEARCH: VERSION A What is this survey about? This survey is about your views on taking part in medical research. We want to understand what you think about

More information

National Survey of Young Adults on HIV/AIDS

National Survey of Young Adults on HIV/AIDS Topline Kaiser Family Foundation National Survey of Young Adults on HIV/AIDS November 30, 2017 The 2017 Kaiser Family Foundation National Survey of Young Adults on HIV/AIDS is based on interviews with

More information

A New Look at the Awareness and Use of Personal Medication Records: Five Years Later

A New Look at the Awareness and Use of Personal Medication Records: Five Years Later A New Look at the Awareness and Use of Personal Medication Records: July 2010 A New Look at Awareness and Use of Personal Medication Records: Data Collected by Social Science Research Solutions (SSRS)

More information

Harvard Opinion Research Program Harvard School of Public Health INFLUENZA A(H1N1)/ SWINE FLU SURVEY III. June 22-28, 2009

Harvard Opinion Research Program Harvard School of Public Health INFLUENZA A(H1N1)/ SWINE FLU SURVEY III. June 22-28, 2009 Harvard Opinion Research Program Harvard School of Public Health INFLUENZA A(H1N1)/ SWINE FLU SURVEY III June 22-28, 2009 Research Team: Robert J. Blendon, Harvard School of Public Health, Project Director

More information

Your Prescription Card. Your guide for savings.

Your Prescription Card. Your guide for savings. Kent State University P.O. Box 5190 Kent, OH 44242-0001 13578-00001_PM JOHN Q SAMPLE 2215 SANDERS RD NBT 2215-5 NORTHBROOK, IL 60062 Your Prescription Card. Your guide for savings. 00001 Dear Plan Member,

More information

Medication Therapy Management: Improving Health and Saving Money

Medication Therapy Management: Improving Health and Saving Money Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system

More information

Your Prescription Card. Your guide for savings.

Your Prescription Card. Your guide for savings. 3 Paragon Drive Montvale, NJ 07645 >00001 00001 001 P50708 _PM 7873 GROUP JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 APDNCLDJDKDIFPAKHPANEMFK AJCLLKEBEKNJJBNMPKGOKIKK AMBPIBPEAKHEIOBKFGFBOMMK

More information

Americans Current Views on Smoking 2013: An AARP Bulletin Survey

Americans Current Views on Smoking 2013: An AARP Bulletin Survey Americans Current Views on Smoking 2013: An AARP Bulletin Survey November 2013 Americans Current Views on Smoking 2013: An AARP Bulletin Survey Report Prepared by Al Hollenbeck, Ph.D. Copyright 2013 AARP

More information

Have you been paying for your prescription drugs? Stop!

Have you been paying for your prescription drugs? Stop! Dear Valued Medtipster Member: Have you been paying for your prescription drugs? Stop! Free prescription drugs are NOW just a Medtipster ID card away. Follow the steps below to obtain thousands of generic

More information

PLEASE FILL OUT & RETURN

PLEASE FILL OUT & RETURN PLEASE FILL OUT & RETURN MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM CONSENT and AUTHORIZATION for RELEASE of INFORMATION I agree to participate in the Medication Therapy Management (MTM) Program. I will

More information

BLACK RESIDENTS VIEWS ON HIV/AIDS IN THE DISTRICT OF COLUMBIA

BLACK RESIDENTS VIEWS ON HIV/AIDS IN THE DISTRICT OF COLUMBIA PUBLIC OPINION DISPARITIES & PUBLIC OPINION DATA NOTE A joint product of the Disparities Policy Project and Public Opinion and Survey Research October 2011 BLACK RESIDENTS VIEWS ON HIV/AIDS IN THE DISTRICT

More information

Prescription Switching and Reduced LDL-C Goal Attainment

Prescription Switching and Reduced LDL-C Goal Attainment Prescription Switching and Reduced LDL-C Goal Attainment JoAnne M. Foody, MD, FACC, FAHA Brigham and Women's Hospital, Boston, MA Disclosures Consultant for Merck and Pfizer Why Address Adherence? Increasing

More information

DENTAL BENEFITS: A BRIDGE TO ORAL HEALTH & WELLNESS

DENTAL BENEFITS: A BRIDGE TO ORAL HEALTH & WELLNESS R GUARDIAN WORKPLACE BENEFITS STUDY SM 5TH ANNUAL DENTAL BENEFITS: A BRIDGE TO ORAL HEALTH & WELLNESS Dental benefits utilization, especially for preventive services, contributes to better oral health

More information

Lewis & Clark National Estimation and Awareness Study

Lewis & Clark National Estimation and Awareness Study Lewis & Clark National Estimation and Awareness Study Prepared by for the Institute for Tourism and Recreation Research and Montana's Tourism Advisory Council Institute for Tourism and Recreation Research

More information

Working Papers Project on the Public and Biological Security Harvard School of Public Health 17.

Working Papers Project on the Public and Biological Security Harvard School of Public Health 17. Working Papers Project on the Public and Biological Security Harvard School of Public Health 17. FLU VACCINE SURVEY Robert J. Blendon, Harvard School of Public Health, Project Director John M. Benson,

More information

THE PUBLIC S PRIORITIES FOR CONGRESS AND PRESIDENT TRUMP IN THE POST- THANKSGIVING PERIOD

THE PUBLIC S PRIORITIES FOR CONGRESS AND PRESIDENT TRUMP IN THE POST- THANKSGIVING PERIOD THE PUBLIC S PRIORITIES FOR CONGRESS AND PRESIDENT TRUMP IN THE POST- THANKSGIVING PERIOD December 2017 1 TABLE OF CONTENTS I. Top Priorities for Congress and President Trump.... 3 II. The Affordable Care

More information

Modernized Reference Drug Program

Modernized Reference Drug Program Modernized Reference Drug Program Monitoring Report For the period ending May 31, 2017 Issued: November 2017 Published by: Pharmaceutical Services Division and Health Sector Information, Analysis and Reporting

More information

Trends in Ohioans Health Status and Income

Trends in Ohioans Health Status and Income October 200 Trends in Ohioans Health Status and Income Since 2005, household incomes in Ohio have steadily declined. In 2005, 65% of Ohio adults were living in households with an annual income over 200%

More information

Appendix C CHANGING THE TRAJECTORY:

Appendix C CHANGING THE TRAJECTORY: Appendix C CHANGING THE TRAJECTORY: Impact of a Hypothetical Treatment That Slows the Progression of Alzheimer s In addition to the delayed onset scenario discussed in the report, another potential scenario

More information

Consumer Reports Diet Survey

Consumer Reports Diet Survey EMBARGOED UNTIL: 6 PM, EST, May 7, 2007 Consumer Reports Diet Survey April 2007 1 Method This report presents the findings of a telephone survey conducted by the Consumer Reports National Research Center

More information

RECEIVING YOUR PERMANENT

RECEIVING YOUR PERMANENT 00001 JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 3118-00001_PM City of Savannah 132 E. Broughton Street Savannah, GA 31401 THIS IS A ONE-TIME CARD TO BE USED UNTIL YOUR PERMANENT CARD ARRIVES

More information

Getting started with Prime

Getting started with Prime Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the

More information

FlexRx 6-Tier. SM Pharmacy Benefit Guide

FlexRx 6-Tier. SM Pharmacy Benefit Guide FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many

More information

[H1N1 New Mother Poll] Weighted Topline March 24, 2010

[H1N1 New Mother Poll] Weighted Topline March 24, 2010 H1N1 New Poll Topline Summary [H1N1 New Poll] Weighted Topline March 24, 2010 Knowledge Networks fielded this study on behalf of the Harvard School of Public Health. Interviews were collected from January

More information

Dear Member: We look forward to serving you. Sincerely, Express Scripts

Dear Member: We look forward to serving you. Sincerely, Express Scripts Dear Member: Welcome to Express Scripts, the company Eastern Kentucky University has chosen to manage your prescription drug plan. As one of the nation s leading prescription benefit managers, Express

More information

Cost-Motivated Treatment Changes in Commercial Claims:

Cost-Motivated Treatment Changes in Commercial Claims: Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical

More information

National Survey of Young Adults on HIV/AIDS

National Survey of Young Adults on HIV/AIDS REPORT National Survey of Young Adults on HIV/AIDS November 2017 Kaiser Family Foundation Introduction More than three and a half decades have passed since the first case of AIDS. An entire generation

More information

Issue Brief. Women are living longer than ever. A woman who is 65

Issue Brief. Women are living longer than ever. A woman who is 65 September 2000 Issue Brief Living Longer, Staying Well: Promoting Good Health for Older Women Karen Scott Collins and Erin Strumpf The Commonwealth Fund is a private foundation established in 1918 by Anna

More information

Understanding the Value of Generic Drugs

Understanding the Value of Generic Drugs Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher

More information

Alzheimer s disease affects patients and their caregivers. experience employment complications,

Alzheimer s disease affects patients and their caregivers. experience employment complications, Alzheimer s Disease and Dementia A growing challenge The majority of the elderly population with Alzheimer s disease and related dementia are in fair to poor physical health, and experience limitations

More information

Per Capita Health Care Spending on Diabetes:

Per Capita Health Care Spending on Diabetes: Issue Brief #10 May 2015 Per Capita Health Care Spending on Diabetes: 2009-2013 Diabetes is a costly chronic condition in the United States, medical costs and productivity loss attributable to diabetes

More information

A LOOK AT ABUSE-DETERRENT OPIOIDS

A LOOK AT ABUSE-DETERRENT OPIOIDS JULY 2017 Drugs Under Review ICER s report reviewed evidence on ten abuse-deterrent formulations (ADF) of opioids. Nine of the drugs were extended release (ER) opioids, and one was immediate release (IR).

More information

2017 FOOD & HEALTH SURVEY A Focus on Older Adults Funded by

2017 FOOD & HEALTH SURVEY A Focus on Older Adults Funded by A Focus on Older Adults 50-80 TABLE OF CONTENTS Background & Methodology 3 Demographics 4 Healthy Eating 7 Food Confusion 23 Packaged Foods 32 Food Values 37 Background The International Food Information

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

Important News From HealthQuest

Important News From HealthQuest HR Contacts Below are the February 2018 HealthQuest announcements to share with your employees. Please ask supervisors to provide this information to employees who do not use email. Thank you very much!

More information

Views and Experiences Related to Women s Health in Texas

Views and Experiences Related to Women s Health in Texas October 2018 Views and Experiences Related to s Health in Texas Selected Findings from the Kaiser Family Foundation/Episcopal Health Foundation 2018 Texas Health Policy Survey Prepared by: Liz Hamel, Bryan

More information

[H1N1 Pregnant Women Poll] Weighted Topline March 24, 2010

[H1N1 Pregnant Women Poll] Weighted Topline March 24, 2010 H1N1 Women Poll Topline Summary [H1N1 Women Poll] Weighted Topline March 24, 2010 Knowledge Networks fielded this study on behalf of the Harvard School of Public Health. Interviews were collected from

More information

Welcome to your. Pharmacy Services Guide. Many of our stores are open 24 hours. To find one near you, visit or call SHOP CVS.

Welcome to your. Pharmacy Services Guide. Many of our stores are open 24 hours. To find one near you, visit   or call SHOP CVS. Welcome to your Many of our stores are open 24 hours. To find one near you, visit www.cvs.com or call 1-800-SHOP CVS. Pharmacy Services Guide 06530RXS09 - Item #456748 11/08 Supplying you with health information

More information

Increasing the Cigarette Tax Rate in Wyoming to Maintain State Programs: An AARP Survey

Increasing the Cigarette Tax Rate in Wyoming to Maintain State Programs: An AARP Survey Increasing the Cigarette Tax Rate in Wyoming to Maintain State Programs: An AARP Survey Increasing the Cigarette Tax Rate in Wyoming to Maintain State Programs: An AARP Survey Data Collected by Southeastern

More information

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help William Shrank MD MSHS Division of Pharmacoepidemiology & Pharmacoeconomics Harvard Medical School wshrank@partners.org

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information

Executive Summary. Lupus Awareness Survey. October 2012

Executive Summary. Lupus Awareness Survey. October 2012 Executive Summary Lupus Awareness Survey October 2012 GfK Roper Public Affairs & Corporate Communications Lupus Awareness Survey October 2012 Executive Summary A recent survey of American adults conducted

More information

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan 2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that

More information

NATIONAL SURVEY OF YOUNG ADULTS ON HIV/AIDS

NATIONAL SURVEY OF YOUNG ADULTS ON HIV/AIDS NATIONAL SURVEY OF YOUNG ADULTS ON HIV/AIDS Kaiser Family Foundation November 30, 2017 Introduction More than three and a half decades have passed since the first case of AIDS. An entire generation has

More information

medicaid and the The Role of Medicaid for People with Diabetes

medicaid and the The Role of Medicaid for People with Diabetes on medicaid and the uninsured The Role of for People with Diabetes November 2012 Introduction Diabetes is one of the most prevalent chronic conditions and a leading cause of death in the United States.

More information

Medication Adherence Survey Highlights. A Survey of Upstate New York, 2017

Medication Adherence Survey Highlights. A Survey of Upstate New York, 2017 Medication Adherence Survey Highlights A Survey of Upstate New York, 2017 Survey Methods Method and Design Excellus BCBS commissioned One Research to conduct an online survey of upstate New York adults.

More information

HYPERKALEMIA: SURVEY OF AWARENESS AND EXPERIENCE AMONG ADULTS WITH CKD

HYPERKALEMIA: SURVEY OF AWARENESS AND EXPERIENCE AMONG ADULTS WITH CKD HYPERKALEMIA: SURVEY OF AWARENESS AND EXPERIENCE AMONG ADULTS WITH CKD A Report of Findings March 6, 2017 TABLE OF CONTENTS Section Page READING OPTIONS: 5-in-1 Drill-down Report... iii ACKNOWLEDGEMENTS...

More information

Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences?

Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences? Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences? Results from a National Survey of Pharmacists and Patients Ameet Sarpatwari, J.D., Ph.D. Instructor in Medicine,

More information

paint a realistic picture of your organization s health

paint a realistic picture of your organization s health plan analytics paint a realistic picture of your organization s health Impressionism has no place in your health care benefit plan. Arm yourself with the facts. Uses up-to-date client-specific data Clears

More information

Coventry Health Care of Georgia, Inc.

Coventry Health Care of Georgia, Inc. Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan

More information

Estimate of the Net Cost of A Prior Authorization Requirement for Certain Mental Health Medications. Prepared by. Driscoll & Fleeter.

Estimate of the Net Cost of A Prior Authorization Requirement for Certain Mental Health Medications. Prepared by. Driscoll & Fleeter. Estimate of the Net Cost of A Prior Authorization Requirement for Certain Mental Health Medications Prepared by Driscoll & Fleeter for NAMI Ohio The National Alliance on Mental Illness Revised August 2008

More information

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit: The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day

More information

Gallup-Palmer College of Chiropractic Annual Report Americans Views of Prescription Pain Medication and Chiropractic Care

Gallup-Palmer College of Chiropractic Annual Report Americans Views of Prescription Pain Medication and Chiropractic Care Gallup-Palmer College of Chiropractic Annual Report Americans Views of Prescription Pain Medication and Chiropractic Care Table of Contents 4 Copyright Standards 5 Executive Summary 7 Introduction 8 Significant

More information

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah Evaluation of a Medicaid Psychotropic Drug Management Program in Utah Dominick Esposito James M. Verdier 2008 SAMHSA/CMS Invitational Conference on Medicaid and Mental Health Service/Substance Abuse Treatment

More information

Therapeutics Initiative A SHORT HISTORY

Therapeutics Initiative A SHORT HISTORY Therapeutics Initiative A SHORT HISTORY Therapeutics Initiative, 1994 (10 individuals) Mission: To provide physicians and pharmacists with up-to-date, evidence-based, practical information on prescription

More information

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment American Hospital association December 2012 TrendWatch Are Medicare Patients Getting Sicker? Today, Medicare covers more than 48 million people, and that number is growing rapidly baby boomers are reaching

More information

Safe, effective, affordable drug choices: online tool for payers and patients.

Safe, effective, affordable drug choices: online tool for payers and patients. Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers

More information

Introduction: Statistics, Data and Statistical Thinking Part II

Introduction: Statistics, Data and Statistical Thinking Part II Introduction: Statistics, Data and Statistical Thinking Part II FREC/STAT 608 Dr. Tom Ilvento Department of Food and Resource Economics Let s Continue with our introduction We need terms and definitions

More information

Confusion or Memory Loss Behavioral Risk Factor Surveillance System (NYS BRFSS) New York State Department of Health

Confusion or Memory Loss Behavioral Risk Factor Surveillance System (NYS BRFSS) New York State Department of Health Confusion or Memory Loss Behavioral Risk Factor Surveillance System (NYS BRFSS) New York State Department of Health Committee on the Public Health Dimensions of Cognitive Aging April 11, 2014 Patricia

More information

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences

More information

2016 PRC Community Health Needs Assessment

2016 PRC Community Health Needs Assessment 2016 PRC Community Health Needs Assessment Staunton City, Waynesboro City, and Augusta County, Virginia Prepared for: Augusta Health By Professional Research Consultants, Inc. The PRC Community Health

More information

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.

More information

Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses

Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses May 16, 2018 Name Address Re: Impact of Prohibiting HIV Prescription Drug Co-pay Cards from Counting Towards Deductibles and Maximum Out-of-Pocket Expenses Dear : We the 60 undersigned organizations of

More information

How Doctors Feel About Electronic Health Records. National Physician Poll by The Harris Poll

How Doctors Feel About Electronic Health Records. National Physician Poll by The Harris Poll How Doctors Feel About Electronic Health Records National Physician Poll by The Harris Poll 1 Background, Objectives, and Methodology New research from Stanford Medicine, conducted with The Harris Poll

More information

AARP/American Speech-Language-Hearing Association (ASHA)

AARP/American Speech-Language-Hearing Association (ASHA) AARP/American Speech-Language-Hearing Association (ASHA) National Poll on Hearing Health Results Summary John Geraci (jgeraci@cruxresearch.com) The right information for the right decisions. Crux Research,

More information

Food Labeling Survey ~ January 2019

Food Labeling Survey ~ January 2019 Food Labeling Survey ~ January 2019 1 Introduction Research Objective Understand consumer attitudes towards healthy labels and different food packaging aspects that drive purchase behavior. Sampling Research

More information

Pharmacy benefit guide

Pharmacy benefit guide FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications

More information

Economics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol

Economics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol s of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol Summary Evidence Tables Study Author (Year) Bunting (2008) Prepost Incomplete

More information

National Sleep Foundation

National Sleep Foundation National Sleep Foundation National Sleep Foundation 2003 Prepared by: Date: March 10, 2003 National Sleep Foundation 1522 K Street, Suite 500, NW Washington, DC 20005 Ph: (202) 347-3471 Fax: (202) 347-3472

More information

COPYRIGHTED MATERIAL. Introduction

COPYRIGHTED MATERIAL. Introduction 1 Introduction Pharmacology is the science of drugs and their effects on biological systems. A drug can be defined as a chemical that can cause a change in a biological system; the important biological

More information

Exhibit 2 - YHP Plan Changes Service YHP Benefit Aetna Durable Medical Equipment including orthotics Prosthetic Devices Home Health Care $ 100 ded/80% to $ 5,000 annual maximum 100% up to $5,000 max Agreed

More information

Chapter 6: Healthcare Expenditures for Persons with CKD

Chapter 6: Healthcare Expenditures for Persons with CKD Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial

More information

BOSTON GLOBE/HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH PRESCRIPTION PAINKILLER ABUSE: U.S. ATTITUDES

BOSTON GLOBE/HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH PRESCRIPTION PAINKILLER ABUSE: U.S. ATTITUDES BOSTON GLOBE/HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH PRESCRIPTION PAINKILLER ABUSE: U.S. ATTITUDES This survey was conducted for the Boston Globe and the Harvard T.H. Chan School of Public Health via

More information

Value of Hospice Benefit to Medicaid Programs

Value of Hospice Benefit to Medicaid Programs One Pennsylvania Plaza, 38 th Floor New York, NY 10119 Tel 212-279-7166 Fax 212-629-5657 www.milliman.com Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce

More information

Religion, Reproductive Health and Access to Services: A National Survey of Women. Conducted for Catholics for a Free Choice

Religion, Reproductive Health and Access to Services: A National Survey of Women. Conducted for Catholics for a Free Choice RESEARCH AND COMMUNICATIONS Religion, Reproductive Health and Access to Services: A National Survey of Women Conducted for Catholics for a Free Choice By Belden Russonello & Stewart April 2000 1320 19TH

More information

Alliance for Aging Research Key Findings from Public Survey on Early Alzheimer's Diagnosis

Alliance for Aging Research Key Findings from Public Survey on Early Alzheimer's Diagnosis Alliance for Aging Research Key Findings from Public Survey on Early Alzheimer's Diagnosis Avalere Health An Inovalon Company August 2018 Methodology Avalere fielded a nationally representative telephone

More information

2018 Travelers Prescription Drug Plan High Deductible + HSA Plan

2018 Travelers Prescription Drug Plan High Deductible + HSA Plan 2018 Travelers Prescription Drug Plan High Deductible + HSA Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that section National Preferred Formulary

More information

UnitedHealthcare Enrollment Service Area Nationwide. UnitedHealthcare Group

UnitedHealthcare Enrollment Service Area Nationwide. UnitedHealthcare Group UnitedHealthcare v UnitedHealthcare Enrollment Service Area Nationwide UnitedHealthcare Group The Value of UnitedHealthcare and the PHIP Partnership National coverage that follows you where ever you are

More information

Overweight and Obesity Rates Among Upstate New York Adults

Overweight and Obesity Rates Among Upstate New York Adults T H E F A C T S A B O U T Overweight and Obesity Rates Among Upstate New York Adults Upstate New York Obesity Rate: 27.5% Overweight Rate: 35.5% Increase in the combined overweight/ obesity rate from 2003

More information

UnitedHealthcare Enrollment Service Area Nationwide. UnitedHealthcare Group

UnitedHealthcare Enrollment Service Area Nationwide. UnitedHealthcare Group UnitedHealthcare v UnitedHealthcare Enrollment Service Area Nationwide UnitedHealthcare Group The Value of UnitedHealthcare and the PHIP Partnership National coverage that follows you where ever you are

More information

To Cover or Not To Cover? A Review of Medication Coverage Guidelines. Dr. Sherita D. Castille, Pharm D Clinical Pharmacist. Agenda.

To Cover or Not To Cover? A Review of Medication Coverage Guidelines. Dr. Sherita D. Castille, Pharm D Clinical Pharmacist. Agenda. To Cover or t To Cover? A Review of Medication Coverage Guidelines Dr. Sherita D. Castille, Pharm D Clinical Pharmacist Agenda 2 Overview Define key Medicare terms Determine relatedness to terminal prognosis

More information

PLEASE PRINT PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER

PLEASE PRINT PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER NORTHERN VIRGINIA CENTER FOR ARTHRITIS PLEASE PRINT PATIENT REGISTRATION Patient s Name: DOB: Sex: Address: PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER Home#( ) [

More information

Carotid Ultrasound Scans for Assessing Cardiovascular Risk

Carotid Ultrasound Scans for Assessing Cardiovascular Risk Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/carotid-ultrasound-scans-for-assessing-cardiovascularrisk/4004/

More information

C A LIFORNIA HEALTHCARE FOUNDATION. Drilling Down: Access, Affordability, and Consumer Perceptions in Adult Dental Health

C A LIFORNIA HEALTHCARE FOUNDATION. Drilling Down: Access, Affordability, and Consumer Perceptions in Adult Dental Health C A LIFORNIA HEALTHCARE FOUNDATION s n a p s h o t Drilling Down: Access, Affordability, and Consumer Perceptions in 2008 Introduction Although many Californians have dental insurance, even those with

More information

Michael J. Negrete, PharmD Chief Executive Officer

Michael J. Negrete, PharmD Chief Executive Officer Making the Most of Your Medications Michael J. Negrete, PharmD Chief Executive Officer 2 Drivers of Increasing Drug Spending Three main factors: Price Increases 24% Drug Mix 28% 3 Utilization 48% Aging

More information

Public Policy Agenda 2016

Public Policy Agenda 2016 Public Policy Agenda 2016 1 in 26 Americans will have epilepsy over the course of their lifetime. Nearly three million children and adults in the United States have epilepsy. Epilepsy is defined as an

More information

2017 FAQs. Dental Plan. Frequently Asked Questions from employees

2017 FAQs. Dental Plan. Frequently Asked Questions from employees 2017 FAQs Dental Plan Frequently Asked Questions from employees September 2016 Dental plan Questions we ve heard our employees ask Here are some commonly asked questions about the Dental plan that our

More information

Cost of Mental Health Care

Cost of Mental Health Care Section 4 Cost of Mental Health Care Per capita mental health spending for Americans with a mental health diagnosis has increased among children, peaking in. For adults, the spending has been more stable.

More information

Commonly asked questions about genetic testing for hereditary cancer

Commonly asked questions about genetic testing for hereditary cancer Commonly asked questions about genetic testing for hereditary cancer Understanding genetic testing for hereditary cancer What is hereditary cancer? In some cases, cancer is caused by genetic changes (or

More information